Acinetobacter baumannii is a major nosocomial pathogen causing human infections with
significant mortality rates. In most cases, infections are acquired through exposure to A …

Background Acinetobacter baumannii (A. baumannii) is an opportunistic pathogen that
poses dangerous health threat. It is a main cause of biofilm-associated infections that are …

Acinetobacter species, particularly Acinetobacter baumannii, is the first pathogen on the
critical priority list of pathogens for novel antibiotics to become a “red-alert” human …

Biofilm-forming multidrug-resistant Acinetobacter baumannii has emerged as a global
pathogen. This study investigated the impact of biofilm formation by A. baumannii on …

Acinetobacter baumannii is a frequent cause of hospital-acquired pneumonia, and has
recently increased in incidence as the causative agent of severe disease in troops wounded …

Bacterial biofilms are a serious public-health problem worldwide. In recent years, the rates of
antibiotic-resistant Gram-negative bacteria associated with biofilm-forming activity have …

Acinetobacter baumannii is a multidrug-resistant opportunistic pathogen that affects patients
with a compromised immune system and is becoming increasingly important as a hospital …

Acinetobacter baumannii, an important emerging pathogen of nosocomial infections, is
known for its ability to form biofilms. Biofilm formation increases the survival rate of A …

Objectives To determine the in vitro stability and efficacy of colistin, tigecycline and
levofloxacin alone or in combination with clarithromycin and/or heparin as lock solutions …

Background Acinetobacter baumannii is a nosocomial pathogen that has emerged as a
major threat in the health-care settings, particularly intensive care units (ICUs). The aim of …